<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-126216" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neutrophilia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tahir</surname>
            <given-names>Nayha</given-names>
          </name>
          <aff>Northwestern hospital Mchenry IL, Rosalind Franklin University, Chicago Medical School</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zahra</surname>
            <given-names>Farah</given-names>
          </name>
          <aff>Northwestern Mchenry/RFMUS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nayha Tahir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Farah Zahra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-126216.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neutrophilia is defined as a higher neutrophil count in the blood than the normal reference range of absolute neutrophil count. Neutrophilia can be seen in infections, inflammation, and/or neoplastic processes. Further evaluation is often necessary. An absolute neutrophil count (ANC), defined as the percent of neutrophils in the bloodstream and adults, typically ranges between 2500 to 7000 neutrophils/microL. An increase in the WBC count of more than 11,000 cells/microL is defined as leukocytosis. Neutrophilia is the most common type of leukocytosis and is defined as an increase in the absolute neutrophil count of approximately more than 7700 neutrophils/microL (11,000 cells/microL x 70 percent), i.e., two standard deviations above the mean. This activity reviews the pathophysiology, causes, evaluation, and treatment of neutrophilia and highlights the role of the interprofessional team in evaluating and treating patients with neutrophilia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the pathophysiology of neutrophilia.</p></list-item><list-item><p>Identify the etiologies of neutrophilia.</p></list-item><list-item><p>Describe the common physical exam findings in patients with neutrophilia.</p></list-item><list-item><p>Outline how an interprofessional team can coordinate care to treat patients with neutrophilia and obtain the best outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=126216&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=126216">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-126216.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neutrophils are historically defined as "soldiers of our innate immune system." They are the first line of cells recruited at the site of infection and attack, ingest, and digest microorganisms by producing reactive oxygen species.<xref ref-type="bibr" rid="article-126216.r1">[1]</xref>&#x000a0;They also play a vital role in acute and chronic inflammatory settings and autoimmune disorders.<xref ref-type="bibr" rid="article-126216.r2">[2]</xref>&#x000a0;In adults, the approximate normal range of white blood cell (WBC) count is 4000 to 11,000 cells/microL, out of which 60% to 70% are mature neutrophils circulating in peripheral blood.<xref ref-type="bibr" rid="article-126216.r3">[3]</xref>&#x000a0;</p>
        <p>An absolute neutrophil count (ANC), defined as the percent of neutrophils in the bloodstream and adults, typically ranges between 2500 to 7000 neutrophils/microL. An increase in the WBC count of more than 11,000 cells/microL is defined as leukocytosis. Neutrophilia is the most common type of leukocytosis. It is defined as an increase in the absolute neutrophil count of approximately more than 7700 neutrophils/microL (11,000 cells/microL x 70 percent), i.e., two standard deviations above the mean.</p>
      </sec>
      <sec id="article-126216.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Causes of Neutrophilia are classified into the following categories:</p>
        <list list-type="bullet">
          <list-item>
            <p>Factitious neutrophilia; neutrophilia due to various artifacts encountered during blood sample handling in laboratory settings</p>
          </list-item>
          <list-item>
            <p>Primary Neutrophilia; neutrophilia due to abnormal increased neutrophils production by bone marrow due to impaired neutrophil production regulation.</p>
          </list-item>
          <list-item>
            <p>Secondary Neutrophilia; reactive neutrophilia can respond to a wide variety of stimuli mentioned in detail below.</p>
          </list-item>
        </list>
        <p>
<bold>Factitious Neutrophilia</bold>
</p>
        <p>Factitious neutrophilia can be seen in the blood samples that are either inadequately anticoagulated with citrate or heparin&#x000a0;or are EDTA- based anticoagulated, causing platelet clumping in an automated cell counter leading to falsely elevated neutrophil count. A repeat blood sample with adequate anticoagulation (with heparin or citrate) and an examination of the peripheral blood smear (showing platelet clumping) can help resolve this problem.<xref ref-type="bibr" rid="article-126216.r4">[4]</xref><xref ref-type="bibr" rid="article-126216.r5">[5]</xref>&#x000a0;Another possibility in which neutrophil count can be falsely elevated is precipitated cryoglobulin particles in a blood sample. Cryoglobulin is a cold insoluble protein, and a repeat blood sample at body temperature should resolve this issue.<xref ref-type="bibr" rid="article-126216.r6">[6]</xref></p>
        <p>
<bold>Primary Neutrophilia</bold>
</p>
        <p>Chronic Idiopathic Leukocytosis:&#x000a0;Given neutrophilia is defined as an ANC of at least two standard deviations above the mean, neutrophil counts can vary considerably among asymptomatic healthy individuals, and 2.5 percent of the population can be considered to have neutrophilia based on the definition mentioned above. Serial evaluations may be required in an average healthy individual with mild neutrophilia to rule out the absence of underlying pathology. Since neutrophil count regulation is also genetically controlled, evaluation of a sibling's or parent s blood count can be helpful in this situation.<xref ref-type="bibr" rid="article-126216.r7">[7]</xref></p>
        <p>Myeloproliferative Neoplasms (MPN): MPNs are characterized by excess and autonomous production of red blood cells, white blood cells, and platelets, thus can be a cause of primary neutrophilia. MPNs associated with neutrophilia include Chronic myeloid leukemia (CML), essential thrombocythemia (ET), polycythemia vera (PV), chronic myelomonocytic leukemia, chronic neutrophilic leukemia, Juvenile myelomonocytic leukemia (JMML).<xref ref-type="bibr" rid="article-126216.r8">[8]</xref><xref ref-type="bibr" rid="article-126216.r9">[9]</xref></p>
        <p>Genetic/ Inherited neutrophilia: The subset of the population affected by this category is neonates and children, with some disorders being detected in adulthood. Leukocyte adhesion factor deficiency is a rare but life-threatening disorder characterized by a defect in leukocyte adhesion molecules, leading to marked leukocytosis, recurrent infections, and delayed umbilical cord separation.<xref ref-type="bibr" rid="article-126216.r10">[10]</xref>&#x000a0;Other causes include congenital anomalies and leukemoid reaction, transient myeloproliferative disorder [TMD] of Down syndrome, familial cold urticaria, and leukocytosis, hereditary chronic neutrophilia (also known as chronic neutrophilic leukemia).<xref ref-type="bibr" rid="article-126216.r11">[11]</xref><xref ref-type="bibr" rid="article-126216.r12">[12]</xref></p>
        <p>
<bold>Secondary Neutrophilia&#x000a0;</bold>
</p>
        <p><bold>&#x000a0;</bold>Infection/Inflammation; The most common cause of secondary neutrophilia is infection and inflammation. Bacterial infections are usually associated with left shift (i.e., an increase in the percentage of band forms of leukocytes), toxic granulations, and D&#x000f6;hle bodies on peripheral smear.<xref ref-type="bibr" rid="article-126216.r13">[13]</xref>&#x000a0;Whereas viral infections may have a high neutrophil count with atypical lymphocytes. Worth mentioning here is a leukemoid reaction, i.e., WBC count of more than 50,000 cells/microL, caused by various infections such as clostridium difficile, tuberculosis, and medications such as ATRA and some nonhematological malignancies. It is essential to distinguish leukemoid reaction from acute leukemia, which is a hematological malignancy. Both acute and chronic inflammation can lead to neutrophilia, to name a few, including Still disease of young, juvenile, and adult-onset rheumatoid arthritis, granulomatous disease, vasculitis, myositis, chronic hepatitis, and inflammatory bowel disease.<xref ref-type="bibr" rid="article-126216.r14">[14]</xref>&#x000a0;</p>
        <p>Nonhematological neoplasms: Neutrophilia can be seen in solid tumor malignancies. Mechanisms leading to increased neutrophil count can be a paraneoplastic leukemoid reaction, bone marrow metastasis, nonspecific tumor-related inflammation, infections, and high-dose corticosteroids for tumor therapy.<xref ref-type="bibr" rid="article-126216.r15">[15]</xref></p>
        <p>Medications: Many medications can cause neutrophilia by various mechanisms, some of which are listed below.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Recombinant granulocyte and granulocyte-macrophage colony-stimulating factors (G-CSF or GM-CSF), All-trans retinoic acid; Increase neutrophil count via direct stimulation of bone marrow myelopoiesis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Glucocorticoids, Plerixafor; Increase neutrophil count by causing the release of granulocytes from the bone marrow into circulation.</p>
          </list-item>
          <list-item>
            <p>Other drugs include lithium and catecholamines.&#x000a0;</p>
          </list-item>
        </list>
        <p>Many medications can cause neutrophilia due to adverse drug reactions, i.e., allergic or inflammatory responses to a drug.</p>
        <p>Others: secondary neutrophilia may also result from various stimuli. These stimuli may include physical or emotional stress, vigorous exercise, temperature changes, seizure activity, cigarette smoking, surgery, obesity, asplenia&#x000a0;or&#x000a0;hyposplenism, and generalized bone marrow stimulation, such as in hemolysis.<xref ref-type="bibr" rid="article-126216.r16">[16]</xref><xref ref-type="bibr" rid="article-126216.r17">[17]</xref><xref ref-type="bibr" rid="article-126216.r18">[18]</xref></p>
      </sec>
      <sec id="article-126216.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>There is a limitation in predicting which patients are at increased risk of developing neutrophilia, given multiple contributing factors. Certain social factors like smoking status, stress, and exercise level can also impact neutrophilia risk. There are more consistent ethnical differences among patients with neutropenia than neutrophilia patients; relative to white people, black people have a lower total WBC count and lower neutrophil count. However, the Latino population is noted to have a higher leukocyte count (mean difference 0.16&#x000d7;10^9/L) and higher neutrophil count (mean difference 0.11&#x000d7;10^9/L) compared to the white population.<xref ref-type="bibr" rid="article-126216.r19">[19]</xref></p>
      </sec>
      <sec id="article-126216.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Circulating neutrophils are mature neutrophils in transit from the bone marrow into the peripheral blood. The life span of neutrophils in bone marrow is approximately ten days, 2&#x000a0;to 3 days in peripheral tissue, and approximately less than 24 hr. in circulation.<xref ref-type="bibr" rid="article-126216.r20">[20]</xref>&#x000a0;The production, proliferation, differentiation, and entry of neutrophils in peripheral blood are tightly regulated by cytokines&#x000a0;and controlled by various transcription and growth factors.<xref ref-type="bibr" rid="article-126216.r21">[21]</xref><xref ref-type="bibr" rid="article-126216.r22">[22]</xref><xref ref-type="bibr" rid="article-126216.r23">[23]</xref>&#x000a0;Neutrophilia can be due to aberrant neutrophils' production by the bone marrow, demargination of neutrophils into the bloodstream, and reactive response to infection, inflammation, and allergic reaction to the medication.</p>
      </sec>
      <sec id="article-126216.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Examination of peripheral blood smears can be beneficial in distinguishing various causes of neutrophilia. Platelet clumping can be seen on peripheral smears in factitious neutrophilia. Myelocytes, metamyelocytes, and increased band forms are seen in severe infections or CML. The presence of toxic granulations and Dohle bodies can also be seen in various infectious and inflammatory states.</p>
        <p>Granulomatous diseases are characterized by granulomata, which are defined as the localized accumulation of activated epithelioid macrophages. In Leukocyte adhesion factor deficiency(LAD), marked neutrophilia accompanied by mild lymphocytosis can be seen even in the absence of any ongoing infection. If there is an ongoing infection, then biopsies of infected tissues can show inflammatory infiltrates devoid of neutrophils.</p>
      </sec>
      <sec id="article-126216.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History should be focused on the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Evidence of active or prior infection and or inflammation</p>
          </list-item>
          <list-item>
            <p>Prior complete blood count (CBC) results</p>
          </list-item>
          <list-item>
            <p>Any recent medication changes</p>
          </list-item>
          <list-item>
            <p>Evaluation of hematological or non-hematological malignancies (recent weight loss, decreased appetite, swollen glands, new palpable mass, generalized body ache, fatigue, night sweats, fever or new cold symptoms, etc.)</p>
          </list-item>
          <list-item>
            <p>Family history of neutrophilia</p>
          </list-item>
          <list-item>
            <p>History of vigorous exercise, cigarette smoking, new physical or emotional stress</p>
          </list-item>
          <list-item>
            <p>History of functional or surgical asplenia</p>
          </list-item>
        </list>
        <p>Physical examination, in general, should be comprehensive and focus on ruling out above mentioned history clues.</p>
        <list list-type="bullet">
          <list-item>
            <p>Vitals assessment for fever, tachycardia</p>
          </list-item>
          <list-item>
            <p>Head and neck examination for facial and conjunctival pallor and lymphadenopathy</p>
          </list-item>
          <list-item>
            <p>Pulmonary examination for decreased breath sounds or any added breath sounds</p>
          </list-item>
          <list-item>
            <p>Abdominal examination for abdominal distention, tenderness, mass, and hepatosplenomegaly</p>
          </list-item>
          <list-item>
            <p>Musculoskeletal examination for joints erythema, tenderness, swelling, and or deformity</p>
          </list-item>
          <list-item>
            <p>Skin examination for any new lesions, nodules, and color changes</p>
          </list-item>
        </list>
        <p>Clinical manifestations in LAD are periodontitis, recurrent skin and mucosal infections, absent pus formation, poor wound healing, and delayed umbilical cord separation.</p>
      </sec>
      <sec id="article-126216.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>CBC and peripheral blood smear:&#x000a0;Evaluation of neutrophilia can be started by reviewing CBC with differential and confirming automated differential with a manual by reviewing peripheral blood smear. A peripheral blood smear review can also help differentiate causes of neutrophilia, as mentioned above in the histopathology section.&#x000a0;</p>
        <p>
<bold>Other Laboratory Studies</bold>
</p>
        <p>Certain laboratory studies can help us distinguish primary versus reactive neutrophilia, such as&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory markers, including ESR, CRP, LDH, ferritin</p>
          </list-item>
          <list-item>
            <p>Liver and renal function tests.</p>
          </list-item>
          <list-item>
            <p>Coagulation profile including APTT, PT/INR, fibrinogen, D dimer</p>
          </list-item>
          <list-item>
            <p>Blood culture, sputum culture, urine culture, wound culture, stool culture, and cerebrospinal fluid analysis (chemistry, histopathology, and culture).&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Clostridium difficile testing</p>
          </list-item>
        </list>
        <p>
<bold>Special Tests</bold>
</p>
        <p>Other tests that can help diagnose neutrophilia once CBC and peripheral blood smear have been reviewed are bone marrow biopsy, flow cytometry, and molecular/genetic testing.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Bone marrow biopsy helps establish the diagnosis of various hematological and non-hematological malignancies invading bone marrow. The biopsy can be utilized to run morphological analysis, flow cytometry, and molecular testing.</p>
          </list-item>
          <list-item>
            <p>Flow cytometry can help diagnose various MPNs, such as CML, PV, and ET, by immunophenotyping peripheral blood.</p>
          </list-item>
          <list-item>
            <p>LAD can be diagnosed by molecular testing and or flow cytometry.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Imaging</bold>
</p>
        <p>Imaging that can help differentiate causes of neutrophilia include.</p>
        <list list-type="bullet">
          <list-item>
            <p>Computed tomography (CT) of the head and neck, chest, abdomen, and pelvis.</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging of the head and neck, chest, abdomen, and pelvis if CT was inconclusive</p>
          </list-item>
          <list-item>
            <p>Positron emission test PET scan</p>
          </list-item>
          <list-item>
            <p>Chest Radiography</p>
          </list-item>
          <list-item>
            <p>Diagnostic ultrasonography</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-126216.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of neutrophilia is based on treating the underlying cause of neutrophilia. In a leukemoid reaction where the WBC count is more than 50,000, emergent leucopheresis, aggressive hydration, and cytotoxic therapy with hydroxyurea are indicated to prevent hypercoagulability-associated complications. Antibiotic and anti-inflammatory therapies should be undertaken for neutrophilia associated with infection/inflammation.</p>
        <p>Medications noted to cause neutrophilia should be carefully monitored and may need to be discontinued if leading to complications. MPNs are usually treated with cytoreductive drugs; the commonly used is hydroxyurea&#x000a0;with serial monitoring of CBC. Specific treatment options for CML include tyrosine kinase inhibitor (TKI) therapy with imatinib&#x000a0;which inhibits bcr-abl tyrosine kinase, the abnormal gene product of Philadelphia chromosome t (9;22) in CML, and allogeneic hematopoietic stem cell transplant (HCT).<xref ref-type="bibr" rid="article-126216.r24">[24]</xref><xref ref-type="bibr" rid="article-126216.r25">[25]</xref><xref ref-type="bibr" rid="article-126216.r26">[26]</xref>&#x000a0;</p>
        <p>Referral to a hematologist should be considered as a part of the workup for MPNs.</p>
      </sec>
      <sec id="article-126216.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis of neutrophilia includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infections including bacterial, viral, fungal, and parasitic</p>
          </list-item>
          <list-item>
            <p>Acute and chronic inflammation, e.g., granulomatous diseases, vasculitis, inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Leukemoid reaction</p>
          </list-item>
          <list-item>
            <p>Hematological and non-hematological malignancies</p>
          </list-item>
          <list-item>
            <p>Medications</p>
          </list-item>
          <list-item>
            <p>Asplenia or hyposplenia</p>
          </list-item>
          <list-item>
            <p>Physical and emotional stimuli (stress, active smoking, vigorous exercise, pregnancy, obesity)</p>
          </list-item>
          <list-item>
            <p>Tissue damage, e.g., surgery, trauma, burns</p>
          </list-item>
          <list-item>
            <p>Laboratory artifacts</p>
          </list-item>
          <list-item>
            <p>Inherited causes like LAD, hereditary neutrophilia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-126216.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of neutrophilia depends on the prognosis of the underlying cause of neutrophilia. Neutrophilia seen in infection/inflammatory state resolves with treatment of these states. Neutrophilia associated with medications can also resolve once either treatment is over or the drug is discontinued. The prognosis in CML has been drastically improved with the introduction of TKIs, including Imatinib and HCT.<xref ref-type="bibr" rid="article-126216.r27">[27]</xref>&#x000a0;HCT has also successfully improved survival in LAD patients.<xref ref-type="bibr" rid="article-126216.r28">[28]</xref></p>
      </sec>
      <sec id="article-126216.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of neutrophilia are those that are of the causes of neutrophilia, such as</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypercoagulability associated with leukemoid reactions</p>
          </list-item>
          <list-item>
            <p>Bacteremia, septic shock, and multiorgan failure in untreated infections</p>
          </list-item>
          <list-item>
            <p>Impaired wound healing, severe periodontitis, severe mental impairment, and failure to thrive in untreated LAD</p>
          </list-item>
          <list-item>
            <p>Thrombosis, hemorrhage, transformation to acute leukemia, and fibrosis are seen in untreated MPNs<xref ref-type="bibr" rid="article-126216.r29">[29]</xref><xref ref-type="bibr" rid="article-126216.r30">[30]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-126216.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>An infectious disease specialist should evaluate patients with infection-associated neutrophilia both in inpatient and outpatient settings. Hematology/Oncology consultation should be considered in patients with hematological and non-hematological malignancies associated with neutrophilia. To rule out LAD, a pediatric consultation should be considered in children presenting with poor wound healing, periodontitis, and repetitive infections.</p>
      </sec>
      <sec id="article-126216.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Educate patients about smoking cessation, weight loss, balanced diet, and relaxation techniques for neutrophilia seen in various physical and emotional stimuli. Educate patients about the side effects of medications like ATRA, lithium, and G CSF that can cause neutrophilia.</p>
      </sec>
      <sec id="article-126216.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Due to the complexity of this condition, management of neutrophilia-associated conditions requires an interprofessional team of health care professionals, including hospital physicians, primary care physicians, specialists including infectious disease specialists, hematologists/oncologists, pediatricians, microbiologists, specialty-trained nurses, and pharmacists working together collaboratively to enhance patient-centered care and improve outcomes. Specialists should recommend treatment options, including antimicrobials, cytoreductive therapies, leucopheresis, immunotherapy, and HCT. Pharmacists should review the indication, dosage, interactions, and contraindications of medications. Nurses taking care of these patients should monitor signs and symptoms associated with neutrophilia-related conditions and report emergent concerns to hospitalists and specialists. Thus, the morbidity and mortality related to neutrophilia-related conditions can be lowered through an interprofessional team approach. [Level 5]</p>
      </sec>
      <sec id="article-126216.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=126216&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=126216">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/neutrophilia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=126216">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/126216/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=126216">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-126216.s17">
        <fig id="article-126216.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Picture of a granuloma (without necrosis) as seen through a microscope on a glass slide. The tissue on the slide is stained with two standard dyes (hematoxylin: blue, eosin: pink) to make it visible. The granuloma in this picture was found in a lymph node of a patient with Mycobacterium avium infection. Contributed by Wikimedia Commons, Sanjay Mukhopadhyay (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1280px-Granuloma_mac" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-126216.s18">
        <fig id="article-126216.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Blast crisis, Leukemia, CML Contributed by Centers of Disease Control and Prevention (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="15271-microscopic-view-of-blast-crisis-of-chronic-myelogenous-leukemia-pv" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-126216.s19">
        <fig id="article-126216.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Blast phase Chronic Myeloid Leukemia Contributed by Rina Eden, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CML__BM__Blast__Transformation__with__Eos" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-126216.s20">
        <fig id="article-126216.image.f4" position="float" orientation="portrait">
          <caption>
            <p>A hematoxylin and eosin (H&#x00026;E) stained slide showing platelet clumping around a neutrophil. Contributed by Dr Wendy Ward, senior pathologist at Northwestern Medicine hospital McHerny IL.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="platelet__clumping__jpg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-126216.s21">
        <fig id="article-126216.image.f5" position="float" orientation="portrait">
          <caption>
            <p>A Hematoxylin and Eosin (H&#x00026;E) stained slide showing D&#x000f6;hle bodies that are light blue-gray, oval, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophil (arrow). Contributed by Dr Wendy Ward, Senior pathologist at Northwestern Medicine Hospital, McHenry, IL.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="dohle__bodies__jpg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-126216.s22">
        <title>References</title>
        <ref id="article-126216.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The role of chemokines in neutrophil biology.</article-title>
            <source>Front Biosci</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>13</volume>
            <fpage>2400</fpage>
            <page-range>2400-7</page-range>
            <pub-id pub-id-type="pmid">17981721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolaczkowska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kubes</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Neutrophil recruitment and function in health and inflammation.</article-title>
            <source>Nat Rev Immunol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-75</page-range>
            <pub-id pub-id-type="pmid">23435331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hollowell</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>van Assendelft</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Gunter</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Najjar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>C</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention, National Center for Health Statistics</collab>
            </person-group>
            <article-title>Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94.</article-title>
            <source>Vital Health Stat 11</source>
            <year>2005</year>
            <month>Mar</month>
            <issue>247</issue>
            <fpage>1</fpage>
            <page-range>1-156</page-range>
            <pub-id pub-id-type="pmid">15782774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solanki</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Blackburn</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Spurious leukocytosis and thrombocytopenia. A dual phenomenon caused by clumping of platelets in vitro.</article-title>
            <source>JAMA</source>
            <year>1983</year>
            <month>Nov</month>
            <day>11</day>
            <volume>250</volume>
            <issue>18</issue>
            <fpage>2514</fpage>
            <page-range>2514-5</page-range>
            <pub-id pub-id-type="pmid">6632146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savage</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Pseudoleukocytosis due to EDTA-induced platelet clumping.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1984</year>
            <month>Mar</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>317</fpage>
            <page-range>317-22</page-range>
            <pub-id pub-id-type="pmid">6422738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Parapia</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Pseudoleucocytosis and pseudothrombocytosis due to cryoglobulinaemia.</article-title>
            <source>J Clin Pathol</source>
            <year>1987</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>120</fpage>
            <page-range>120-1</page-range>
            <pub-id pub-id-type="pmid">3818970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ward</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Chronic idiopathic leukocytosis.</article-title>
            <source>Ann Intern Med</source>
            <year>1971</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-8</page-range>
            <pub-id pub-id-type="pmid">5558646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tefferi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic myeloid disorders: Classification and treatment overview.</article-title>
            <source>Semin Hematol</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1 Suppl 2</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">11242595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arber</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Orazi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hasserjian</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Borowitz</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Le Beau</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bloomfield</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Cazzola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vardiman</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.</article-title>
            <source>Blood</source>
            <year>2016</year>
            <month>May</month>
            <day>19</day>
            <volume>127</volume>
            <issue>20</issue>
            <fpage>2391</fpage>
            <page-range>2391-405</page-range>
            <pub-id pub-id-type="pmid">27069254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genetic etiologies of leukocyte adhesion defects.</article-title>
            <source>Curr Opin Immunol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>481</fpage>
            <page-range>481-6</page-range>
            <pub-id pub-id-type="pmid">19647987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elliott</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tefferi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.</article-title>
            <source>Am J Hematol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>93</volume>
            <issue>4</issue>
            <fpage>578</fpage>
            <page-range>578-587</page-range>
            <pub-id pub-id-type="pmid">29512199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinstein</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome.</article-title>
            <source>Clin Haematol</source>
            <year>1978</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-54</page-range>
            <pub-id pub-id-type="pmid">148990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wanahita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Musher</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile.</article-title>
            <source>Clin Infect Dis</source>
            <year>2002</year>
            <month>Jun</month>
            <day>15</day>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>1585</fpage>
            <page-range>1585-92</page-range>
            <pub-id pub-id-type="pmid">12032893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caprilli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Corrao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taddei</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tonelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Torchio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Viscido</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).</article-title>
            <source>Dis Colon Rectum</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>335</fpage>
            <page-range>335-41</page-range>
            <pub-id pub-id-type="pmid">8603558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kontoyiannis</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study.</article-title>
            <source>Cancer</source>
            <year>2009</year>
            <month>Sep</month>
            <day>01</day>
            <volume>115</volume>
            <issue>17</issue>
            <fpage>3919</fpage>
            <page-range>3919-23</page-range>
            <pub-id pub-id-type="pmid">19551882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christensen</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Exercise-induced changes in the blood concentration of leukocyte populations in teenage athletes.</article-title>
            <source>Am J Pediatr Hematol Oncol</source>
            <year>1987</year>
            <season>Summer</season>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-2</page-range>
            <pub-id pub-id-type="pmid">2954481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCarthy</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Melsom</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Leucocytosis induced by exercise.</article-title>
            <source>Br Med J (Clin Res Ed)</source>
            <year>1987</year>
            <month>Sep</month>
            <day>12</day>
            <volume>295</volume>
            <issue>6599</issue>
            <fpage>636</fpage>
            <pub-id pub-id-type="pmid">3117270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McBride</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dacie</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Shapley</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The effect of splenectomy on the leucocyte count.</article-title>
            <source>Br J Haematol</source>
            <year>1968</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-31</page-range>
            <pub-id pub-id-type="pmid">5635603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsieh</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Everhart</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Byrd-Holt</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Tisdale</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences.</article-title>
            <source>Ann Intern Med</source>
            <year>2007</year>
            <month>Apr</month>
            <day>03</day>
            <volume>146</volume>
            <issue>7</issue>
            <fpage>486</fpage>
            <page-range>486-92</page-range>
            <pub-id pub-id-type="pmid">17404350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tak</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tesselaar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pillay</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Borghans</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Koenderman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>What's your age again? Determination of human neutrophil half-lives revisited.</article-title>
            <source>J Leukoc Biol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>595</fpage>
            <page-range>595-601</page-range>
            <pub-id pub-id-type="pmid">23625199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lichtman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Weed</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Pincus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santillo</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>The regulation of the release of granulocytes from normal marrow.</article-title>
            <source>Prog Clin Biol Res</source>
            <year>1977</year>
            <volume>13</volume>
            <fpage>53</fpage>
            <page-range>53-75</page-range>
            <pub-id pub-id-type="pmid">400761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tenen</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Hromas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Licht</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Transcription factors, normal myeloid development, and leukemia.</article-title>
            <source>Blood</source>
            <year>1997</year>
            <month>Jul</month>
            <day>15</day>
            <volume>90</volume>
            <issue>2</issue>
            <fpage>489</fpage>
            <page-range>489-519</page-range>
            <pub-id pub-id-type="pmid">9226149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaushansky</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Lineage-specific hematopoietic growth factors.</article-title>
            <source>N Engl J Med</source>
            <year>2006</year>
            <month>May</month>
            <day>11</day>
            <volume>354</volume>
            <issue>19</issue>
            <fpage>2034</fpage>
            <page-range>2034-45</page-range>
            <pub-id pub-id-type="pmid">16687716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Chronic myeloid leukemia trialists' collaborative group.</article-title>
            <source>Br J Haematol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>573</fpage>
            <page-range>573-6</page-range>
            <pub-id pub-id-type="pmid">10997966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Apperley</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goolden</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Batchelor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Waldmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Hows</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Bone marrow transplantation for patients with chronic myeloid leukemia.</article-title>
            <source>N Engl J Med</source>
            <year>1986</year>
            <month>Jan</month>
            <day>23</day>
            <volume>314</volume>
            <issue>4</issue>
            <fpage>202</fpage>
            <page-range>202-7</page-range>
            <pub-id pub-id-type="pmid">3510388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Majhail</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sobocinski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Horowitz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.</article-title>
            <source>J Clin Oncol</source>
            <year>2010</year>
            <month>Apr</month>
            <day>10</day>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>1888</fpage>
            <page-range>1888-95</page-range>
            <pub-id pub-id-type="pmid">20212247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bower</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bj&#x000f6;rkholm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dickman</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>H&#x000f6;glund</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.</article-title>
            <source>J Clin Oncol</source>
            <year>2016</year>
            <month>Aug</month>
            <day>20</day>
            <volume>34</volume>
            <issue>24</issue>
            <fpage>2851</fpage>
            <page-range>2851-7</page-range>
            <pub-id pub-id-type="pmid">27325849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qasim</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cavazzana-Calvo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eames</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Farinha</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Filopovich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Friedrich</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gennery</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heilmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Landais</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Horwitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Porta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sedlacek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Seger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Slatter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teague</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eapen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Veys</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>836</fpage>
            <page-range>836-40</page-range>
            <pub-id pub-id-type="pmid">19255011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elliott</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tefferi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.</article-title>
            <source>Br J Haematol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-90</page-range>
            <pub-id pub-id-type="pmid">15667529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-126216.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noor</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wilding</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Barcos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sait</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Wetzler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases.</article-title>
            <source>Leuk Res</source>
            <year>2011</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>608</fpage>
            <page-range>608-13</page-range>
            <pub-id pub-id-type="pmid">20727590</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
